Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LOMA LINDA UNIVERSITY MEDICAL CENTER-MURRIETA

NPI: 1588908388 · MURRIETA, CA 92563 · General Acute Care Hospital · NPI assigned 11/16/2012

$70.86M
Total Medicaid Paid
1,008,067
Total Claims
870,728
Beneficiaries
357
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialHILLIARD, ANTHONY (CEO)
NPI Enumeration Date11/16/2012

Related Entities

Other providers sharing the same authorized official: HILLIARD, ANTHONY

ProviderCityStateTotal Paid
LOMA LINDA UNIVERSITY CHILDREN'S HOSPITAL LOMA LINDA CA $107.10M
SEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER REDLANDS CA $19.31M
SEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER LOMA LINDA CA $13.94M
SEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER LOMA LINDA CA $2.13M
SEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER LOMA LINDA CA $227K
LOMA LINDA UNIVERSITY CHILDREN'S HOSPITAL LOMA LINDA CA $194K
SEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER LOMA LINDA CA $4K
SEVENTH-DAY ADVENTISTS LOMA LINDA UNIVERSITY MEDICAL CENTER LOMA LINDA CA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 114,020 $5.06M
2019 117,150 $6.40M
2020 105,079 $7.51M
2021 122,972 $8.59M
2022 157,240 $11.56M
2023 191,469 $15.77M
2024 200,137 $15.97M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 42,676 38,930 $32.97M
0450 Emergency room services 48,703 43,432 $24.47M
99284 Emergency department visit for the evaluation and management, high severity 13,280 12,355 $3.43M
74177 Computed tomography, abdomen and pelvis; with contrast material 10,369 10,163 $666K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,282 3,234 $585K
93458 536 502 $494K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 19,840 18,429 $478K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8,632 8,549 $457K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 11,324 11,046 $420K
74176 Computed tomography, abdomen and pelvis; without contrast material 9,337 9,083 $388K
70450 Computed tomography, head or brain; without contrast material 9,517 9,267 $305K
71045 Radiologic examination, chest; single view 27,824 25,973 $277K
L8699 Prosthetic implant, not otherwise specified 112 45 $259K
80053 Comprehensive metabolic panel 55,014 50,593 $225K
0360 1,555 661 $201K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 8,737 1,421 $197K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 6,894 6,626 $190K
96375 Therapeutic injection; each additional sequential IV push 16,745 14,896 $181K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 4,955 4,645 $167K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,008 964 $154K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,094 1,087 $130K
76705 Ultrasound, abdominal, real time with image documentation; limited 5,306 5,171 $117K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 744 744 $113K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 21,148 19,490 $104K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 2,305 2,267 $102K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 882 881 $102K
71046 Radiologic examination, chest; 2 views 9,307 9,060 $99K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 4,002 3,921 $96K
99232 Subsequent hospital care, per day, moderate complexity 1,408 646 $96K
99221 619 607 $94K
99215 Prolong outpt/office vis 952 924 $86K
71275 Computed tomographic angiography, chest, with contrast material 1,619 1,594 $86K
99223 Prolong inpt eval add15 m 653 645 $80K
96361 Intravenous infusion, hydration; each additional hour 11,321 10,627 $80K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 721 717 $72K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 861 841 $67K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 12,311 11,099 $65K
0510 1,859 1,002 $65K
99233 Prolong inpt eval add15 m 701 346 $63K
J3490 Unclassified drugs 33,170 21,904 $62K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 50,585 46,756 $62K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,452 1,384 $61K
82962 12,171 5,001 $57K
Z7502 1,485 1,459 $56K
99070 44,209 24,819 $56K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,011 4,742 $54K
76830 Ultrasound, transvaginal 2,180 2,145 $52K
93971 2,704 2,617 $51K
76801 2,169 1,945 $50K
0710 1,067 809 $50K
71260 Computed tomography, thorax, diagnostic; with contrast material 1,071 1,033 $49K
93970 1,314 1,237 $48K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 3,145 1,820 $47K
72125 Computed tomography, cervical spine; without contrast material 1,744 1,718 $44K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 247 81 $41K
76700 Ultrasound, abdominal, real time with image documentation; complete 1,180 1,169 $41K
99222 Initial hospital care, per day, moderate complexity 381 374 $40K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 9,761 9,095 $40K
76770 1,341 1,325 $37K
85730 25,880 24,425 $37K
59409 Vaginal delivery only (with or without episiotomy and/or forceps) 45 45 $37K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 237 237 $36K
J7050 Infusion, normal saline solution, 250 cc 7,613 6,539 $33K
99239 Hospital discharge day management, more than 30 minutes 289 287 $31K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 3,930 2,750 $30K
59025 Fetal non-stress test 769 475 $29K
81001 38,563 35,520 $29K
99238 Hospital discharge day management, 30 minutes or less 716 707 $28K
85610 26,257 24,786 $26K
84484 24,937 16,189 $26K
88305 Level IV - Surgical pathology, gross and microscopic examination 442 429 $26K
73630 2,834 2,626 $25K
85027 8,176 7,442 $24K
84703 19,118 17,945 $24K
36415 Collection of venous blood by venipuncture 6,841 6,051 $23K
99231 Subsequent hospital care, per day, straightforward or low complexity 390 383 $23K
99205 Prolong outpt/office vis 115 115 $23K
83690 17,458 16,387 $22K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 231 223 $22K
97750 559 350 $21K
87088 11,742 11,234 $21K
J3010 Injection, fentanyl citrate, 0.1 mg 3,641 3,307 $21K
70496 306 302 $20K
49083 306 166 $20K
74018 3,565 3,295 $20K
72131 792 773 $20K
83880 5,920 5,678 $20K
31579 139 138 $20K
70486 509 503 $18K
78815 Positron emission tomography (PET) for limited area imaging 81 81 $18K
70498 286 281 $18K
92060 270 270 $17K
74183 188 185 $17K
80048 Basic metabolic panel (calcium, ionized) 2,938 2,648 $14K
92579 314 314 $14K
J2704 Injection, propofol, 10 mg 2,499 1,603 $14K
83605 7,723 6,745 $14K
87040 5,957 3,646 $13K
92567 764 763 $13K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 153 150 $13K
J2250 Injection, midazolam hydrochloride, per 1 mg 3,618 3,258 $12K
J7120 Ringers lactate infusion, up to 1000 cc 1,353 1,152 $12K
99218 72 72 $12K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 905 832 $12K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 3,359 2,907 $12K
92582 127 127 $12K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 27 27 $11K
92587 521 520 $11K
73030 1,746 1,655 $11K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 54 54 $11K
86900 5,545 3,807 $11K
73610 1,827 1,732 $11K
82550 12,613 11,812 $11K
Z9725 246 236 $10K
86850 3,523 3,391 $10K
72197 108 106 $10K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 81 81 $10K
73130 1,821 1,687 $10K
0720 288 219 $10K
84443 Thyroid stimulating hormone (TSH) 4,071 3,904 $10K
J1170 Injection, hydromorphone, up to 4 mg 6,667 5,167 $9K
J1644 Injection, heparin sodium, per 1000 units 2,547 1,449 $9K
72100 1,759 1,744 $9K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 1,061 975 $9K
83735 7,298 6,920 $9K
99460 93 93 $9K
70551 Magnetic resonance imaging, brain; without contrast material 124 121 $9K
86328 242 239 $9K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 66 65 $8K
J7060 5% dextrose/water (500 ml = 1 unit) 4,795 4,226 $8K
95720 48 24 $8K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 1,133 1,061 $8K
71250 218 215 $8K
92015 Determination of refractive state 631 631 $8K
J0690 Injection, cefazolin sodium, 500 mg 1,221 1,076 $7K
87070 2,917 2,812 $7K
86901 5,115 3,806 $7K
76536 255 254 $7K
69210 243 242 $7K
84702 3,326 2,869 $7K
90960 End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits 37 37 $7K
93000 558 551 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg 15,308 13,905 $6K
0250 3,238 2,233 $6K
87077 7,292 3,952 $6K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 166 165 $6K
0750 58 26 $6K
82553 6,508 5,913 $6K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed 54 54 $6K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation 174 167 $5K
92557 138 136 $5K
96367 385 362 $5K
88307 54 53 $5K
51798 150 146 $5K
96376 1,568 1,321 $5K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up 95 94 $5K
74178 54 52 $5K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 81 80 $5K
73562 910 810 $5K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 156 42 $5K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 149 134 $4K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 366 359 $4K
72040 812 799 $4K
87430 2,855 2,780 $4K
52000 59 59 $4K
0370 13 12 $4K
00920 31 31 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg 12,286 11,558 $4K
J0136 Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg 485 300 $4K
85379 2,227 2,174 $4K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 712 697 $4K
93248 176 176 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 708 693 $3K
J2270 Injection, morphine sulfate, up to 10 mg 8,058 7,083 $3K
99217 109 70 $3K
76825 40 38 $3K
J0131 Injection, acetaminophen, not otherwise specified,10 mg 356 304 $3K
J7030 Infusion, normal saline solution , 1000 cc 4,146 3,758 $3K
70491 52 52 $3K
73564 311 285 $3K
76376 421 417 $3K
75574 35 35 $3K
86140 2,694 2,623 $3K
74174 36 36 $3K
92556 59 59 $3K
93320 154 149 $3K
31575 29 29 $3K
97799 180 58 $3K
97165 69 12 $2K
00170 Anesthesia for intraoral procedures, including biopsy 13 13 $2K
93976 77 72 $2K
76937 277 274 $2K
80143 907 872 $2K
73590 620 558 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 5,188 4,980 $2K
76776 110 106 $2K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 12 12 $2K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient 30 28 $2K
93325 457 442 $2K
93228 87 87 $2K
88341 16 13 $2K
99224 28 28 $2K
99152 227 222 $2K
93351 26 26 $2K
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 263 122 $2K
73110 466 447 $2K
97602 63 58 $2K
84100 1,891 1,722 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 38 12 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg 2,856 2,553 $2K
84439 1,033 1,002 $2K
52310 13 13 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 2,281 2,169 $2K
0272 1,011 883 $2K
J0360 Injection, hydralazine hcl, up to 20 mg 405 372 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,728 2,617 $2K
85652 2,557 2,489 $2K
85007 2,719 2,604 $2K
97763 46 12 $2K
88350 12 12 $2K
87400 2,741 2,584 $1K
73090 395 376 $1K
73080 253 240 $1K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 136 78 $1K
86923 110 64 $1K
0270 1,056 635 $1K
81003 563 485 $1K
87147 1,902 684 $1K
P9047 Infusion, albumin (human), 25%, 50 ml 25 12 $1K
76642 41 33 $1K
99308 Subsequent nursing facility care, per day, straightforward 56 56 $1K
76827 39 37 $1K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 13 13 $1K
77067 Screening mammography, bilateral, including computer-aided detection 30 30 $1K
81025 1,615 1,550 $1K
88342 36 36 $1K
87205 792 701 $1K
51784 15 15 $1K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 18 13 $1K
93312 12 12 $987.31
P9016 Red blood cells, leukocytes reduced, each unit 20 13 $950.08
J2765 Injection, metoclopramide hcl, up to 10 mg 2,219 2,026 $934.89
72070 262 262 $924.54
90715 432 428 $882.20
93975 18 17 $867.88
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 14 14 $864.20
76942 13 13 $792.00
83036 Hemoglobin; glycosylated (A1C) 255 254 $785.95
99153 Mod sedat endo service >5yrs 27 26 $778.19
93283 20 20 $761.72
86308 987 959 $752.63
92134 25 25 $702.86
82330 146 133 $694.38
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 136 136 $683.49
82803 128 117 $681.21
J2060 Injection, lorazepam, 2 mg 2,350 2,051 $676.56
88313 24 24 $642.90
86318 171 165 $633.46
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 74 73 $623.75
92083 14 14 $609.14
93284 14 13 $608.41
73501 125 121 $566.02
12001 100 100 $561.66
76819 Fetal biophysical profile; without non-stress testing 15 13 $529.46
87186 412 376 $522.36
0100U 224 221 $520.84
73560 167 139 $514.17
82570 117 106 $497.57
0259 2,572 1,673 $493.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 506 496 $478.61
29125 173 172 $477.43
76870 24 24 $469.91
A9270 Non-covered item or service 4,565 2,311 $469.87
95816 13 13 $464.00
92136 13 13 $447.75
84132 261 247 $447.36
Z7610 47 38 $420.62
93244 26 26 $405.27
76882 13 13 $405.16
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 56 56 $402.88
88304 35 35 $400.68
82274 234 231 $390.75
87420 603 563 $378.93
J3370 Injection, vancomycin hcl, 500 mg 383 321 $336.52
74230 13 13 $322.52
84550 200 194 $306.03
S0020 Injection, bupivicaine hydrochloride, 30 ml 67 63 $297.25
73502 14 14 $289.66
88346 12 12 $286.66
J0330 Injection, succinylcholine chloride, up to 20 mg 26 26 $275.70
83615 1,346 1,264 $265.46
93016 18 18 $264.23
J2175 Injection, meperidine hydrochloride, per 100 mg 25 24 $258.62
73565 31 31 $219.19
J2919 Injection, methylprednisolone sodium succinate, 5 mg 245 230 $217.77
97530 Therapeutic activities, direct patient contact, each 15 minutes 55 16 $209.36
72170 32 28 $205.96
93227 12 12 $192.62
85014 124 117 $181.54
82150 268 256 $178.60
J1920 Injection, labetalol hydrochloride, 5 mg 24 24 $176.27
93018 18 18 $174.33
84295 124 118 $168.77
S0164 Injection, pantoprazole sodium, 40 mg 491 456 $161.34
A6453 Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard 116 113 $145.48
73060 40 40 $134.31
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 63 15 $128.49
71020 172 164 $127.14
99281 Emergency department visit for the evaluation and management, self-limited or minor 13 13 $126.61
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 240 235 $114.58
51741 15 15 $112.50
85378 295 282 $112.22
81002 87 85 $108.63
0271 117 114 $103.00
E0112 Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips 124 120 $101.66
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 197 187 $95.72
J0780 Injection, prochlorperazine, up to 10 mg 210 201 $89.09
71100 51 51 $86.81
J1171 Injection, hydromorphone, 0.1 mg 36 34 $85.14
87184 107 92 $83.96
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 265 240 $77.31
73140 12 12 $76.94
84156 34 29 $69.32
82728 13 13 $65.12
84436 233 230 $59.20
0258 514 370 $53.48
29515 24 24 $39.37
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 26 26 $32.00
36410 160 158 $27.24
74022 41 39 $26.81
87280 130 125 $24.85
S0077 Injection, clindamycin phosphate, 300 mg 12 12 $21.88
87210 45 45 $21.78
J3475 Injection, magnesium sulfate, per 500 mg 96 93 $21.48
J0456 Injection, azithromycin, 500 mg 37 35 $16.88
J1815 Injection, insulin, per 5 units 47 40 $15.00
J2470 Injection, pantoprazole sodium, 40 mg 92 89 $13.82
82270 13 13 $7.86
J1940 Injection, furosemide, up to 20 mg 31 28 $5.60
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram 26 26 $4.96
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 131 126 $4.20
99499 90 77 $0.00
G8484 Influenza immunization was not administered, reason not given 16 16 $0.00
73100 27 25 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 65 56 $0.00
86999 51 38 $0.00
J2550 Injection, promethazine hcl, up to 50 mg 18 17 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 20 20 $0.00
3078F 26 24 $0.00
71010 119 115 $0.00
74019 59 58 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 812 793 $0.00
73552 39 36 $0.00
85651 26 26 $0.00
J7042 5% dextrose/normal saline (500 ml = 1 unit) 13 13 $0.00
3074F 15 13 $0.00
36430 14 12 $0.00